Echinomycin, a Small-Molecule Inhibitor of Hypoxia-Inducible Factor-1 DNA-Binding Activity
Dehe Kong(Science Applications International Corporation (United States)), Giovanni Melillo(AstraZeneca (Brazil))
Cited by 510
Related Papers
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy
|European Journal of Cancer|2018|267
Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition
|Molecular Cancer Therapeutics|2009|170
Induction of Apoptosis in Human Cancer Cells by Candidaspongiolide, a Novel Sponge Polyketide
|JNCI Journal of the National Cancer Institute|2008|47